Concepedia

Adrienne E. Balitza

AE

Statistics

Publications

4

Citations

211

H-Index

4

Active since

2003

Affiliations

United States Military Academy(Current)

Adrienne E. Balitza is an author at United States Military Academy specializing in pharmacology, molecular pharmacology, and tyrosine kinase inhibitors.

Publications per year

2003–2008

4

Publications

4

Allosteric inhibitors of Akt1 and Akt2: A naphthyridinone with efficacy in an A2780 tumor xenograft model

Mark T. Bilodeau, Adrienne E. Balitza, J. M. HOFFMAN et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 81 citations · Full text

, , +14

Potent <i>N</i>-(1,3-Thiazol-2-yl)pyridin-2-amine Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors with Excellent Pharmacokinetics and Low Affinity for the hERG Ion Channel

Mark T. Bilodeau, Adrienne E. Balitza, Timothy J. Koester et al. · Journal of Medicinal Chemistry · 2004 · 60 citations · Full text

, , +17

Design and synthesis of 3,7-diarylimidazopyridines as inhibitors of the VEGF-receptor KDR

Zhicai Wu, Mark E. Fraley, Mark T. Bilodeau et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 42 citations · Full text

, , +10

2,4-Disubstituted pyrimidines: A novel class of KDR kinase inhibitors

Peter J. Manley, Adrienne E. Balitza, Mark T. Bilodeau et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 28 citations · Full text

, , +11

1–4 of 4